9-34645848-A-ATTTTTTT

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2

The ENST00000605275.1(GALT):​n.209-815_209-809dup variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00079 ( 4 hom., cov: 0)

Consequence

GALT
ENST00000605275.1 intron, non_coding_transcript

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.901
Variant links:
Genes affected
GALT (HGNC:4135): (galactose-1-phosphate uridylyltransferase) Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP6
Variant 9-34645848-A-ATTTTTTT is Benign according to our data. Variant chr9-34645848-A-ATTTTTTT is described in ClinVar as [Benign]. Clinvar id is 1343439.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000788 (99/125612) while in subpopulation SAS AF= 0.0107 (39/3650). AF 95% confidence interval is 0.00803. There are 4 homozygotes in gnomad4. There are 55 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GALTENST00000605275.1 linkuse as main transcriptn.209-815_209-809dup intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.000796
AC:
100
AN:
125634
Hom.:
4
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00137
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000492
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000236
Gnomad SAS
AF:
0.0109
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00388
Gnomad NFE
AF:
0.000114
Gnomad OTH
AF:
0.000589
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.000788
AC:
99
AN:
125612
Hom.:
4
Cov.:
0
AF XY:
0.000924
AC XY:
55
AN XY:
59556
show subpopulations
Gnomad4 AFR
AF:
0.00137
Gnomad4 AMR
AF:
0.000491
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000236
Gnomad4 SAS
AF:
0.0107
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000114
Gnomad4 OTH
AF:
0.000585

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 22, 2022Variant summary: GALT c.-843_-837dupTTTTTTT is located in the untranscribed region upstream of the GALT gene region. The variant allele was found at a frequency of 0.00079 in 124530 control chromosomes in the gnomAD database (v3.1.2 dataset), including 4 homozygotes. The variant is predominantly found within the South Asian subpopulation at a frequency of 0.011. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 4-fold of the estimated maximal expected allele frequency for a pathogenic variant in GALT causing Galactosemia phenotype (0.0029), strongly suggesting that the variant is a benign polymorphism. To our knowledge, no occurrence of c.-843_-837dupTTTTTTT in individuals affected with Galactosemia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs549043849; hg19: chr9-34645845; API